On the occasion of World Mental Health Day, the World Health Organization (WHO) will host a webinar on 8 October 2020 to place a special spotlight on the linkages between TB and mental health disorders.

Nearly 5000 people virtually joined the official UN General Assembly side-event: "Progress and multisectoral action towards achieving global targets to end TB" co-organized by the World Health Organization (WHO) and the Russian Federation on 23 September. Held on the sidelines of the 75th UN General Assembly, the event brought together a distinguished line-up of speakers spanning WHO and UN leadership, health ministers, partners and civil society.

The World Health Organization and the Russian Federation are organizing an official UN General Assembly virtual side event on 23 September 2020, Progress and multisectoral action towards achieving global targets to end TB.

The World Health Organization released target product profiles to drive the rapid development of novel TB preventive treatment. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

Member States of the World Health Organization adopt the Global Strategy for TB Research and Innovation at 73rd World Health Assembly.

29 July 2020 | GENEVA - The World Health Organization (WHO) and the Stop TB Partnership’s New Diagnostics Working Group (NDWG) launched today a framework for the evaluation of new tests for tuberculosis infection. The document provides details on study design, populations, reference standards, sample size calculation and data analysis to guide the future development of these tests.

24 July 2020, Geneva | WHO is initiating the development of updated guidelines on the management of TB in children and adolescents. The second edition of the Guidance for national tuberculosis programmes on the management of tuberculosis in children was published in 2014. Since then, several recommendations included in this guidance have been updated as part of other WHO guidelines, including recommendations on TB preventive treatment, treatment of drug-resistant TB, rapid diagnostics. An update to the TB screening guidelines is currently in process.

22 July 2020, Geneva | The World Health Organization (WHO) Global Tuberculosis Programme has initiated a process for the collection and assessment of evidence on whether the dosing of rifampicin, isoniazid, ethambutol and pyrazinamide requires further optimization to safely improve treatment success and reduce unfavourable treatment outcomes in TB patients on first-line treatment regimens.

The World Health Organization (WHO) will host a webinar on 9 July 2020 to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment.

An introductory meeting of the World Health Organization (WHO) Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) was held on 24-25 June 2020. The purpose of the meeting was to orient new STAG-TB members on their roles, the work of WHO and its Global TB Program and to overview the draft 2020 progress report of the UN Secretary General on TB.